Cargando…
Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route
BACKGROUND: Oral vaccine is highly desired for infectious disease which is caused by pathogens infection through the mucosal surface. The design of suitable vaccine delivery system is ongoing for the antigen protection from the harsh gastric environment and target to the Peyer’s patches to induce su...
Autores principales: | Qi, Xingmei, Lu, Qian, Hu, JingPing, Xiong, Sidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449988/ https://www.ncbi.nlm.nih.gov/pubmed/30947747 http://dx.doi.org/10.1186/s12934-019-1115-z |
Ejemplares similares
-
Intein-mediated backbone cyclization of VP1 protein enhanced protection of CVB3-induced viral myocarditis
por: Qi, Xingmei, et al.
Publicado: (2017) -
An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine
por: Gao, Yue, et al.
Publicado: (2021) -
Dpep2 Emerging as a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis
por: Yang, Xiaoli, et al.
Publicado: (2019) -
Transmissible endoplasmic reticulum stress from myocardiocytes to macrophages is pivotal for the pathogenesis of CVB3-induced viral myocarditis
por: Zhang, Hui, et al.
Publicado: (2017) -
Remission of CVB3-induced myocarditis with Astragaloside IV treatment requires A20 (TNFAIP3) up-regulation
por: Gui, Jun, et al.
Publicado: (2015)